Bridgebio Pharma Inc Earnings

Bridgebio Pharma Inc’s revenue jumped 4318.01% since last year same period to $120.7Mn in the Q3 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated 9.17% jump in its revenue since last 3-months.

Bridgebio Pharma Inc’s net profit fell -12.78% since last year same period to $-182.74Mn in the Q3 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated -0.46% fall in its net profits since last 3-months.

Bridgebio Pharma Inc’s net profit margin jumped 97.45% since last year same period to -151.4% in the Q3 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated 7.97% jump in its net profit margins since last 3-months.

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a 10.18% jump from last quarter’s estimates.

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.64.

Bridgebio Pharma Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Bridgebio Pharma Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.